Risk Factors for Breast Cancer and Expression of Insulin-Like Growth Factor-2 (IGF-2) in Women with Breast Cancer in Wuhan City, China

Purpose: The purpose of this study was to explore the risk factors for breast cancer and establish the expression rate of IGF-2 in female patients. Methods: A case control study with 500 people in case group and 500 people in control group. A self-administered questionnaire was used to investigate risk factors for breast cancer. All cases were interviewed during a household survey. Immune-histochemical method was used to inspect the expression of IGF-2 in different tissues (benign breast lesions, breast cancer and tumor-adjacent tissue). Results: Multivariate adjusted odds ratios and 95% confidence intervals were calculated using unconditional logistic regression. High body mass index (OR = 1.012,95% CI = 1.008-1.016), working attributes (OR = 1.004, 95% CI = 1.002 = 1.006), long menstrual period (OR = 1.007, 95% CI = 1.005-1.009), high parity OR = 1.003, 95% CI = 1.001-1.005), frequent artificial abortion (OR = 1.004, 95% CI = 1.001-1.005), family history of cancer (OR = 1.003, 95% CI = 1.000-1.005), period of night shift (OR = 1.003, 95% CI = 1.001-1.006), live in high risk environment (OR = 1.005, 95% CI = 1.002-1.008), and family problems (OR = 1.010, 95% CI = 1.005-1.014) were associated with increased risk for breast cancer. In this study, good sleeping status, positive coping strategies, subjective support, and utility degree of social support were associated with reduced risk for breast cancer (OR = 0.998, 0.997, 0.985, 0.998 respectively; 95% CI = 0.996-1.000, 0.994-1.000, 0.980-0.989, 0.996-1.000, respectively). In benign breast lesions, breast cancer and tumor-adjacent tissue, IGF-2 was mainly expressed in the cytoplasm, but its expression rate was different (p < 0.05). Conclusions: The incidence of breast cancer is a common result of multiple factors. IGF-2 is involved in the development of breast cancer, and its expression varies in different tissues (benign breast lesions, breast cancer and tumor-adjacent tissue).